Stevanato Group S.p.A. $STVN Shares Bought by Bamco Inc. NY

Bamco Inc. NY grew its holdings in Stevanato Group S.p.A. (NYSE:STVN) by 4.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,973,759 shares of the company’s stock after acquiring an additional 85,709 shares during the period. Bamco Inc. NY owned about 0.65% of Stevanato Group worth $50,824,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in STVN. Farther Finance Advisors LLC purchased a new stake in Stevanato Group during the 3rd quarter worth $44,000. First Horizon Corp purchased a new position in Stevanato Group in the third quarter valued at about $50,000. State of Wyoming lifted its stake in shares of Stevanato Group by 39,216.7% during the second quarter. State of Wyoming now owns 2,359 shares of the company’s stock worth $58,000 after purchasing an additional 2,353 shares in the last quarter. Quantbot Technologies LP acquired a new position in shares of Stevanato Group during the third quarter worth about $68,000. Finally, Van Berkom & Associates Inc. boosted its position in shares of Stevanato Group by 50.6% in the third quarter. Van Berkom & Associates Inc. now owns 3,615 shares of the company’s stock worth $93,000 after buying an additional 1,215 shares during the period.

Analysts Set New Price Targets

STVN has been the topic of several analyst reports. Morgan Stanley dropped their target price on Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating on the stock in a report on Friday, March 6th. Weiss Ratings cut Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday. Wall Street Zen downgraded shares of Stevanato Group from a “buy” rating to a “hold” rating in a research report on Saturday, February 14th. Citigroup reduced their target price on shares of Stevanato Group from $32.00 to $26.00 and set a “buy” rating on the stock in a research report on Thursday, March 5th. Finally, Jefferies Financial Group set a $17.50 target price on shares of Stevanato Group in a research note on Tuesday, February 10th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

Stevanato Group Trading Up 2.7%

NYSE:STVN opened at €15.03 on Monday. The stock has a market cap of $4.55 billion, a price-to-earnings ratio of 25.92, a price-to-earnings-growth ratio of 1.34 and a beta of 0.57. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.26 and a current ratio of 1.76. Stevanato Group S.p.A. has a one year low of €13.91 and a one year high of €28.00. The business’s 50-day simple moving average is €17.06 and its 200 day simple moving average is €21.39.

Stevanato Group Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.